person reading

About Dipna Pharmachem Ltd. - Company Information, Overview, History and Profile

What does Dipna Pharmachem Ltd. do?

Dipna Pharmachem is engaged wholesales chemical products. The Company trades, imports, and exports industrial chemical and pharmaceutical raw materials, APIs, solvents, and formulations. Dipna Pharmachem serves customers in India.

Website: www.dipnapharmachem.com

Dipna Pharmachem Ltd. Management structure

All Gross Remunerations are in INR
Mr. Keyur Nitinbhai Parmar
Chief Financial Officer
-
2024-3-31
Gross Remuneration
Year

Dipna Pharmachem Ltd. Board of directors

All Gross Remunerations are in INR
Keyur Shah
Managing Director
-
2022
Gross Remuneration
Year
Dipna Shah
Director
-
2022
Gross Remuneration
Year
Nandish Jani
Independent Director
-
2022
Gross Remuneration
Year
Chinu Kalal
Independent Director
-
2022
Gross Remuneration
Year
Jitendra Parmar
Independent Director
-
2022
Gross Remuneration
Year

Dipna Pharmachem Ltd. - company history

Dipan Pharmachem Private Limited was incorporated on July 19, 2011. Subsequently, the Company name was changed to "Dipna Pharmachem Private Limited" on March 29, 2012. Later on, it was converted from Private Limited to Public Limited and the name of Company was changed to "Dipna Pharmachem Limited" vide fresh Certificate of Incorporation issued by Registrar of Companies, Ahmedabad dated May 25, 2022. Mr. Keyur Shah, being the Promoter, the Company is engaged in trading and distribution of pharmaceutical raw material and chemical formulation products, also known as APIs (Active Pharmaceutical Ingredients). Presently, its product portfolio comprises of 61 AIPs and AIPs intermediates such as Cephalosporins, Cardiovasculars, Anti - Bactaria, Quinolones, Veterinary, Anti - Virus, Anti - Inflammatory, Neuropsychiatry, Steroid Hormone, other etc. Being a trading and distribution company, it has a pan India market for products. In FY 2022, the Company started trading of chemicals in Ahmedabad. In August 2022, Company made a fresh issue by raising funds through IPO aggregating to Rs 15.2 Cr and by issuing 40,02,000 equity shares of Rs 10/- each.